SMAD7 and hepatocellular carcinoma: Furthermore, SMAD7 was included as one of a target of miR-106b-5p and miR-17-5p, based on reports which SMAD7 might influence cancer cell proliferation and metastasis in hepatocellular carcinoma [21].